The pharmaceutical service provider Vetter is investing over 230 million euros in a new production building at its Ravensburg site, which will house several commercial filling lines. With the completion of the 122-meter-long, 44-meter-wide and 32-meter-high shell, an important milestone has now been reached following the start of construction in November 2021. The company will thus once again increase its commercial production capacities for its global customer base and plans to install the first cleanrooms at the end of 2024.

According to Vetter Managing Director Thomas Otto, “Our new production building signifies our ongoing dedication to support the needs of our customers concerning their complex injectable drug products with regards to packaging systems, specific process requirements and batch sizes. This is just one of several investments we are currently undertaking to manage our sustainable growth.”

Vetter expands laboratory space, filling capacities and warehouse

Further investments include the expansion of laboratory space for analytical services, the expansion of filling capacities through additional commercial production lines at existing sites in the region, the expansion of cold storage and warehousing, and a new warehouse for technical devices and equipment. In addition, the infrastructure and related processes at all global sites are being continuously developed, new preparation rooms are being set up, and the handling of incoming and outgoing materials at the production sites is being further optimized.

Further investments in increasing efficiency and quality of development and production processes

“In our industry, the needs of our customers and the patients they serve continue to evolve,” emphasizes Vetter Managing Director Peter Soelkner. “Our job as a leading CDMO is to act as a strong partner, take the proactive steps necessary to identify relevant industry trends, and thus, to meet the evolving demands of the market through offering adequate resources. Over the coming years, we will continue to make further investments to stay on track with this commitment that we have made as a service provider, from the early development phase to aseptic fill and finish through assembly and packaging services.”